PublicationsA Novel AI – Derived Metric Identifies Favorable Candidates of Focal Therapy of Prostate Cancer and Accurately Predicts Treatment Margin EfficacyMarch 13, 2023
PublicationsDefining Prostate Cancer Focal Therapy Treatment Margins with a Machine Learning Model: Improvement Upon Hemi-Gland AblationMarch 13, 2023
NewsFirst AI-Powered Precision Oncology Platform for Prostate Cancer Care, iQuestTM, Receives FDA ClearanceDecember 13, 2022
NewsCould an Emerging AI Platform Supplant Traditional MRI for Assessing Prostate Cancer?December 7, 2022
News, RecognitionAvenda Health Adds Tech Luminary to Board of Directors and Expands Leadership TeamAugust 26, 2022